C07D 213/78
Carbon atoms having three bonds to hetero atoms, with at the most
Official title: Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D213/78 (Carbon atoms having three bonds to hetero atoms, with at the most) appears on 5,545 US grants and 4,953 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,545
- Published applications
- 4,953
- Assignees
- 1,963
- Inventors
- 15,119
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 76 | 0 |
| 1977 | 92 | 0 |
| 1978 | 102 | 0 |
| 1979 | 55 | 0 |
| 1980 | 74 | 0 |
| 1981 | 61 | 0 |
| 1982 | 64 | 0 |
| 1983 | 69 | 0 |
| 1984 | 48 | 0 |
| 1985 | 71 | 0 |
| 1986 | 60 | 0 |
| 1987 | 69 | 0 |
| 1988 | 72 | 0 |
| 1989 | 80 | 0 |
| 1990 | 100 | 0 |
| 1991 | 87 | 0 |
| 1992 | 96 | 0 |
| 1993 | 73 | 0 |
| 1994 | 83 | 0 |
| 1995 | 73 | 0 |
| 1996 | 81 | 0 |
| 1997 | 104 | 0 |
| 1998 | 96 | 0 |
| 1999 | 98 | 0 |
| 2000 | 102 | 0 |
| 2001 | 127 | 38 |
| 2002 | 158 | 127 |
| 2003 | 114 | 197 |
| 2004 | 122 | 247 |
| 2005 | 92 | 198 |
| 2006 | 127 | 197 |
| 2007 | 100 | 211 |
| 2008 | 118 | 203 |
| 2009 | 121 | 216 |
| 2010 | 159 | 251 |
| 2011 | 138 | 203 |
| 2012 | 161 | 200 |
| 2013 | 181 | 211 |
| 2014 | 196 | 231 |
| 2015 | 197 | 240 |
| 2016 | 211 | 235 |
| 2017 | 196 | 231 |
| 2018 | 161 | 205 |
| 2019 | 159 | 178 |
| 2020 | 140 | 169 |
| 2021 | 115 | 178 |
| 2022 | 89 | 153 |
| 2023 | 99 | 203 |
| 2024 | 84 | 193 |
| 2025 | 114 | 131 |
| 2026 | 80 | 107 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Methods of making nicotinic acid derivatives29 Sep 2026US 12,747,211 B2Syngenta Crop Protection AG
- Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions29 Sep 2026US 12,747,212 B2TMEM16A Limited
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Process for the preparation of 5-chloro-3-alkylsulfanyl-pyridine-2-carboxylic acid amides and carboxylates8 Oct 2026US 2026/0308124 A1Syngenta Crop Protection AG
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Herbicidal derivatives1 Oct 2026US 2026/0293895 A1Syngenta Crop Protection AG
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- Compounds and methods of use1 Oct 2026US 2026/0297089 A1Tango Therapeutics, Inc.
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity167US 5,919,970 AAllergan Sales, Inc. · 1999
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007